益得

+1.25 (+5.14%)最後更新 2026-09-11

台灣 · 上櫃 · 生技醫療業

25.55105成交張數–本益比3.15股價淨值比0.00%殖利率2026-09-11資料日期

ROE 與 ROA

近四季合計;近十年

每股淨值

元

負債比率

負債總額 / 資產總額

現金流量

單季,億元;自由現金流 = 營業現金流 + 資本支出(負值)

季度	資產總額(億)	母公司權益(億)	負債比率	流動比率	每股淨值	ROE(近四季)	ROA(近四季)	營業現金流(億)	自由現金流(億)
2026Q2	23	9	61.0%	1.62	5.01	-47.6%	-19.2%	-0.9	-1.0
2026Q1	23	10	57.4%	0.96	5.56	-48.0%	-17.5%	-0.8	-0.9
2025Q4	24	11	53.2%	1.66	6.17	-40.6%	-16.4%	-0.6	-0.7
2025Q3	25	10	60.4%	1.28	6.06	-39.1%	-14.9%	-1.2	-1.3
2025Q2	27	11	58.6%	1.71	6.95	-30.2%	-12.2%	-0.8	-0.9
2025Q1	24	7	69.3%	0.89	5.28	-41.9%	-15.0%	-1.0	-1.2
2024Q4	24	8	66.0%	1.06	5.90	-37.1%	-14.4%	-0.6	-0.8
2024Q3	25	9	63.2%	1.31	6.61	-42.4%	-14.8%	-0.9	-0.9
2024Q2	26	10	60.7%	1.48	7.31	-37.3%	-14.0%	-0.7	-0.9
2024Q1	27	11	59.8%	0.95	7.97	-32.4%	-12.6%	-0.5	-0.6
2023Q4	27	12	56.9%	1.22	8.50	-30.7%	-12.8%	-0.7	-0.8
2023Q3	24	8	67.1%	0.69	6.82	-35.3%	-13.4%	-0.4	-0.4
2023Q2	25	9	64.4%	0.91	7.55	-31.7%	-13.4%	-0.4	-0.4
2023Q1	25	10	62.4%	1.07	8.15	-30.6%	-13.5%	-0.6	-0.6
2022Q4	26	10	59.6%	1.28	8.82	-27.7%	-12.7%	-0.5	-0.5
2022Q3	26	11	57.4%	4.85	9.61	-27.7%	-12.2%	-0.4	-0.5
2022Q2	24	12	51.3%	3.17	10.22	-25.8%	-12.3%	-0.7	-0.7
2022Q1	25	13	49.5%	3.04	10.93	-23.9%	-11.9%	-0.3	-0.4
2021Q4	26	13	48.6%	1.41	11.50	-22.6%	-11.6%	-0.5	-0.6
2021Q3	24	11	54.4%	0.88	11.02	-23.0%	-11.8%	-0.4	-0.5
2021Q2	25	12	52.9%	1.37	11.73	-21.4%	-11.3%	-0.6	-0.6
2021Q1	26	13	51.2%	2.04	12.53	-18.7%	-10.1%	-0.5	-0.5
2020Q4	26	13	49.3%	2.65	13.19	-17.3%	-9.6%	-0.4	-0.5
2020Q3	24	14	42.9%	1.43	13.75	-20.3%	-11.0%	-0.5	-0.5
2020Q2	25	14	41.3%	2.00	14.37	-20.4%	-11.5%	-0.4	-0.4
2020Q1	25	15	40.3%	1.16	15.03	-20.7%	-12.2%	-0.5	-0.8
2019Q4	26	16	39.8%	1.74	15.61	-20.4%	-12.2%	-0.5	-0.7
2019Q3	25	13	48.7%	0.59	15.76	-20.0%	-11.5%	-0.3	-0.3
2019Q2	25	13	46.3%	0.86	16.79	-17.4%	-10.4%	-0.7	-0.7
2019Q1	24	14	41.7%	0.64	17.75	–	–	-0.4	-0.5
2018Q4	25	15	40.8%	0.92	18.60	–	–	-0.6	-1.0
2018Q3	24	15	36.3%	0.74	19.26	–	–	-0.5	-0.6
2018Q2	24	16	33.3%	0.59	19.96	–	–	–	–